Trending Now
Caduceus Software Systems Corp (OTCMKTS:CSOC) Enters $90B Pet Food Market (ZTS,...
With rumors swirling around the Caduceus Software Systems Corp (OTCMKTS:CSOC) merger story over recent weeks, bears have been on the run and...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Artelo Biosciences Inc. (NASDAQ:ARTL) Announces its Q4 and FY2020 Financial Results...
Artelo Biosciences Inc. (NASDAQ:ARTL) has announced its financial and operating results for Q4 and fiscal 2020 year ended August 31, 2020, and offered a...
MAKE IT MODERN
LATEST REVIEWS
Atossa Therapeutics Inc (NASDAQ:ATOS) Commences Treatment Of A Patient With Ovarian...
Atossa Therapeutics Inc (NASDAQ:ATOS) began treating an ovarian cancer patient with its oral Endoxifen under an expanded pathway permitted previously by the US FDA.
Surgeon-in-Chief,...
MAKE IT MODERN
PERFORMANCE TRAINING
IPO’s to focus on today (AKRO, BCEL, PRVL, PSNL, GO, CMBM)
The futures are green this morning and after 7 straight days of new highs on the SPY and positive news out of...
Recursion (NASDAQ: RXRX) Expands Strategic Partnership With BAYER On Fibrotic Diseases
Recursion (NASDAQ: RXRX) has expanded its current strategic partnership with Bayer AG in Fibrosis. The expanded partnership includes Recursion's robust inferential search abilities based...
Cingulate Surges (CING) on New European Patent for ADHD Treatment and promising further advancements
Cingulate Inc. (NASDAQ: CING), a pioneer in biopharmaceuticals, announced a significant breakthrough with the issuance of a European patent for its leading...
Trillium Therapeutics Inc. (NASDAQ:TRIL) Reports Q3 2020 Financial and Program Updates on TTI-621 and...
Trillium Therapeutics Inc. (NASDAQ:TRIL) has announced its operating and financial results for the three months and nine months ended September 30, 2020.
The company's CEO...
Telehealth Stocks for the Win (TDOC, ISWH, NXGN)
The pandemic represents a disjunction in history for the healthcare system. The technology was already in place before the onset of the global health...
MAKE IT MODERN
